Sight loss linked to other diseases

With an ageing population, more people are affected by sight loss linked to another conditions, like diabetes, an inflammatory condition or Alzheimer’s disease.

Working with partners we currently invest £3.8 million into 50 research projects into these types of conditions to better understand the mechanisms and to develop new treatments. The research we fund uses pioneering approaches, from artificial intelligence to single RNA sequencing. 

For example, Fight for Sight is working with Alzheimer’s UK to fund Dr Pearse Keane from UCL who is using artificial intelligence to analyse a database of over two million eye scans, identifying common features in people with a neurodegenerative disease. This could enable early detection and treatment of Alzheimer’s, which affects an estimated 44 million people worldwide. 

We’re also funding a team at Queen’s University Belfast who, for the first time, are using single RNA sequencing to simultaneously ‘dissect’ out all the cell types within the retina to discover how they are affected during the course of diabetic retinopathy, with a view to developing new treatments.

Read more about our research

Suzie Bushby who was diagnosed with diabetic retinopathy, said:

“I’ve had diabetic retinopathy for four years which has really had a significant impact on mine and my family's life. Every morning I wake up and am worried that my eyes will be worse. Research funded by Fight for Sight gives me hope for the future because it paves the way for new treatments that could make a real difference.”

Diabetic retinopathy

What is it?

Diabetic retinopathy is the most common complication of diabetes and may develop in anyone with type 1 or type 2 diabetes. It affects the light-sensitive layer at the back of the eye (the retina). Diabetic retinopathy currently causes sight loss in approximately 95,000 people in the UK.

Find out more about diabetic retinopathy

Share this page